Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
BRIACELL THERAP (BCTX) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-20.30M |
|
-- |
|
-- |
|
$23.27M |
|
$-23.27M |
|
$2.97M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-20.30M |
|
$-23.27M |
|
$-23.26M |
|
15.62M |
|
15.62M |
|
$-1.30 |
|
$-1.30 |
|
| Balance Sheet Financials | |
$26.95M |
|
-- |
|
$0.22M |
|
$27.16M |
|
$1.80M |
|
-- |
|
$29.14M |
|
$30.94M |
|
$-3.78M |
|
$-3.99M |
|
$-3.78M |
|
15.98M |
|
| Cash Flow Statement Financials | |
$-23.74M |
|
-- |
|
$3.95M |
|
$41.04M |
|
$21.25M |
|
$-19.79M |
|
$2.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.96 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
537.50% |
|
508.55% |
|
-74.74% |
|
537.50% |
|
$-0.24 |
|
$-1.52 |
|
$-1.52 |
|